BLRX ▼ -0.5% - BioLineRx Ltd.
$BLRX BLRX - BioLineRx and Hemispherian Present Preclinical Data Demonstrating Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancer at ESMO 2026
23-OCT-2026 07:00 AM ET
Share this post
More filings for $BLRX
BLRX ▲ +8.1% - BioLineRx Ltd.Oct 8, 2026BLRX ▼ -13.3% - BioLineRx Ltd.Sep 10, 2026BLRX ▲ +11.2% - BioLineRx Ltd.Aug 31, 2026BLRX ▼ -19.9% - BioLineRx Ltd.Aug 28, 2026
View full $BLRX filing history →💬 Comments
Loading comments…
Leave a comment